New 52 Week Low Today

Anavex Life Sciences Corp AVXL:NASDAQ

RT Quote | Last NYSE, VOL From CTA | USD
Last | 3:40 PM EDT
3.70quote price arrow down-0.10 (-2.63%)
Volume
1,593,976
52 week range
3.60 - 10.45
Loading...
  • Open3.76
  • Day High3.80
  • Day Low3.60
  • Prev Close3.80
  • 52 Week High10.45
  • 52 Week High Date12/19/23
  • 52 Week Low3.60
  • 52 Week Low Date04/19/24

Key Stats

  • Market Cap303.816M
  • Shares Out82.11M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.65
  • YTD % Change-60.37

KEY STATS

  • Open3.76
  • Day High3.80
  • Day Low3.60
  • Prev Close3.80
  • 52 Week High10.45
  • 52 Week High Date12/19/23
  • 52 Week Low3.60
  • 52 Week Low Date04/19/24
  • Market Cap303.816M
  • Shares Out82.11M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.65
  • YTD % Change-60.37

RATIOS/PROFITABILITY

  • EPS (TTM)-0.54
  • P/E (TTM)-6.91
  • Fwd P/E (NTM)-6.32
  • EBITDA (TTM)-51.665M
  • ROE (TTM)-31.88%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/07/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Anavex Life Sciences Corp

 

Profile

MORE
Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company. The Company is engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system (CNS) diseases with unmet need. The Company analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound ANAVEX 2-73 is being...
Christopher Missling Ph.D.
Chairman of the Board, President, Chief Executive Officer, Company Secretary
Sandra Boenisch CPA
Principal Financial Officer, Treasurer
Address
630 5Th Avenue, 20Th Floor
New York, NY
10111
United States

Top Peers

SYMBOLLASTCHG%CHG
IVVD
Invivyd Inc
2.29-0.06-2.34%
TNYA
Tenaya Therapeutics Inc
4.25-0.04-0.93%
GLUE
Monte Rosa Therapeutics Inc
5.83-0.09-1.52%
ERAS
Erasca Inc
1.76-0.03-1.68%
ADVM
Adverum Biotechnologies Inc
11.10-0.05-0.45%